Quarterly Results

  • Company Name :
Jubilant Pharmova Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 530019
  • NSE Symbol:
  • JUBLPHARMA
  • P/E(TTM):
  • 0.00
  • ISIN Demat:
  • INE700A01033
  • Div & Yield%:
  • 0.48
  • EPS(TTM):
  • 0.00
  • Book Value(₹):
  • 140.87
  • Market Cap(₹Cr.):
  • 16,677.12
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 66.30 59.50 60.50
Excise Duty 0.00 0.00 0.00
Net Sales 66.30 59.50 60.50
Other Operating Income 0.10 0.00 0.20
Other Income 42.40 2.40 13.00
Total Income 108.80 61.90 73.70
Total Expenditure 54.60 49.20 49.80
PBIDT 54.20 12.70 23.90
Interest 2.50 3.00 3.10
PBDT 51.70 9.70 20.80
Depreciation 1.60 1.50 1.50
Tax 1.40 1.20 5.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 55.10 1.20 0.70
Reported Profit After Tax -6.40 5.80 13.60
Extra-ordinary Items 41.60 1.70 12.70
Adjusted Profit After Extra-ordinary item -48.00 4.10 0.90
EPS (Unit Curr.) -0.40 0.36 0.86
EPS (Adj) (Unit Curr.) -0.40 0.36 0.86
Calculated EPS (Unit Curr.) -0.40 0.36 0.86
Calculated EPS (Adj) (Unit Curr.) -0.40 0.36 0.86
Calculated EPS (Ann.) (Unit Curr.) -1.61 1.46 3.42
Calculated EPS (Adj) (Ann.) (Unit Curr.) -1.61 1.46 3.42
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 15.90 15.90 15.90
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 81.75 21.34 39.50
PBDTM(%) 77.98 16.30 34.38
PATM(%) -9.65 9.75 22.48